MedReleaf Corp. (TSX:LEAF) is the latest cannabis stock to hit the TSX. The stock initially got an unpleasant smack in the face since the IPO happened last Wednesday in the midst of a nasty industry-wide sell-off. At the time of writing, the stock rallied back to around its IPO share price of $9.50.
Could MedReleaf be the spark to reignite the second wave of the green rush? Or will it become a victim of a sell-off?